London, UK, and Cambridge, MA: 18 September 2008 Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announced its preliminary results for the year ended 30 June 2008. These results have been prepared under International Financial Reporting Standards ('IFRS') as adopted for use by the European Union.
